P895: DARATUMUMAB PLUS POMALIDOMIDE AND DEXAMETHASONE (DPD) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND 17P DELETION: UPDATED ANALYSIS OF THE DEDALO PHASE II TRIAL

Bibliographic Details
Title: P895: DARATUMUMAB PLUS POMALIDOMIDE AND DEXAMETHASONE (DPD) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND 17P DELETION: UPDATED ANALYSIS OF THE DEDALO PHASE II TRIAL
Authors: Vittorio Montefusco, Anna Maria Cafro, Gloria Margiotta-Casaluci, Francesca Patriarca, Roberto Mina, Mattia D’agostino, Anna Benedetta Dalla Palma, Rita Rizzi, Angelo Genua, Francesca Fazio, Laura Paris, Angelo Belotti, Ilaria Rizzello, Concetta Conticello, Carmelo Carlo-Stella, Mario Boccadoro
Source: HemaSphere, Vol 7, p e729785d (2023)
Publisher Information: Wiley, 2023.
Publication Year: 2023
Collection: LCC:Diseases of the blood and blood-forming organs
Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2572-9241
Relation: http://journals.lww.com/10.1097/01.HS9.0000970484.72978.5d; https://doaj.org/toc/2572-9241
DOI: 10.1097/01.HS9.0000970484.72978.5d
Access URL: https://doaj.org/article/c18d8975f59b4d80b1aa597a9557ee91
Accession Number: edsdoj.18d8975f59b4d80b1aa597a9557ee91
Database: Directory of Open Access Journals
More Details
ISSN:25729241
DOI:10.1097/01.HS9.0000970484.72978.5d
Published in:HemaSphere
Language:English